DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ advanced 1.41% to $503.50 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.58% to 5,560.83 and the Dow Jones Industrial Average rising 0.75% to 40,527.62.
This was the stock's sixth consecutive day of gains.
Vertex Pharmaceuticals Inc. closed 3.15% below its 52-week high of $519.88, which the company reached on November 8th.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. $(ABBV)$ rose 0.61% to $193.51, Krystal Biotech Inc. (KRYS) rose 0.49% to $170.57, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ remained unchanged.
Trading volume (1.2 M) remained 253,176 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 29, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 29, 2025 16:36 ET (20:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。